Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

Immunological treatment improved both neuropathy and alopecia.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

ILC1-like cells can independently cause alopecia areata.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

DFMO may help control hair growth and treat cancer.

Certain immune cells help hair growth by regulating iron in the skin.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

miR-200a reduces goose fibroblast growth by targeting PITX2 in the Wnt pathway.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Tofacitinib is a promising treatment for children with rheumatic diseases.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.